Earnings News
Quarterly earnings reports, revenue surprises, and EPS results from top companies. Follow earnings season with analyst estimates and post-earnings stock moves.
ON Semiconductor Q2 Beats Estimates, Cash Flow Surge Raises Questions
ON Semiconductor shares gained after Q2 results beat expectations, with revenue and EPS surpassing consensus. However, the company's cash flow growth was aided by working capital changes, raising sustainability concerns.
Celsius Holdings Faces Pre-Earnings Slide as Investors Eye Core Growth
Celsius Holdings (CELH) shares declined 3.4% to $28.23 ahead of Q2 earnings, with investors focused on core brand growth and margin trends. Analysts expect revenue of $887.7 million.
Hims & Hers Stock Rebounds 11% Ahead of Q2 Earnings Test
Hims & Hers shares surged 11% before earnings, erasing FTC-related losses. The focus now shifts to margin recovery and Eucalyptus integration.
Opendoor Shares Surge Ahead of Q2 Report; Margin Outlook in Focus
Opendoor shares climbed 4.5% ahead of Q2 results, with revenue expected near $900M. Investors focus on contribution margin and adjusted EBITDA as the company scales purchases.
CNH Industrial Beats Q2 Forecasts but Faces Stiff Cash Target
CNH Industrial shares climbed after Q2 earnings topped estimates, but a revised cash-flow target for H2 presents a significant challenge.
Plug Power Faces Key Cash Test Ahead of August 10 Earnings
Plug Power's liquidity is under scrutiny ahead of its August 10 earnings, with cash down 27.4% to $162M, prompting a focus on cash conversion.
Grab Stock Climbs Ahead of Q2 Earnings as Superbank Consolidation Draws Focus
Grab shares advanced 3.1% to $3.61 ahead of Q2 earnings, with focus on adjusted EBITDA margins and Superbank consolidation effects on revenue.
Qualcomm Shares Recover as Auto and IoT Growth Softens Handset Slide
Qualcomm shares stabilized Monday as automotive and IoT growth offset 61% of the handset revenue decline, though Q4 EPS guidance fell short.
Snap Stock Surges 6.5% as Investors Eye Margin Expansion Ahead of Q2 Report
Snap (SNAP) shares rose 6.5% ahead of Q2 earnings, with investors focused on margin growth. The company expects $500M in annual cost savings, boosting sentiment.
TG Therapeutics Stock Drops 9.8% Despite Strong BRIUMVI Sales as Costs Surge
TG Therapeutics shares fell 9.8% as Q2 revenue rose 70% but operating income declined 38% on surging costs. Guidance raised modestly.